FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115413209> ?p ?o ?g. }

• W2115413209 endingPage "6849" @default.
• W2115413209 startingPage "6842" @default.
• W2115413209 abstract "Ovarian cancer patients treated with cisplatin-based chemotherapy often develop acquired cisplatin resistance and, consequently, cancer recurrence. The precise nature of chemoresistance remains unclear. In this study, a protein identified to be associated with cisplatin resistance in ovarian cancer cells was investigated in ovarian cancer tissues to address its clinical significance.Antibody microarrays were used to identify proteins consistently differentially expressed across three pairs of cisplatin-sensitive and cisplatin-resistant ovarian cancer cell lines. Immunoblotting was used to confirm observed alteration of protein expression. The protein expression was further evaluated by immunohistochemical staining using tissue microarrays containing various human normal and malignant tissues and 164 surgical specimens derived from primary and recurrent ovarian cancer patients who underwent primary debulking surgery followed by standard chemotherapeutic regimen.Annexin XI was down-regulated in all three cisplatin-resistant cell lines as compared with their parent cells. Annexin XI expression was observed in the majority of human normal organs and decreased in some of the most common human malignancies. The expression level of Annexin XI in first recurrent ovarian cancers was much lower than that in primary ovarian cancers (P = 0.0004). Increased Annexin XI immunoreactivity in ovarian cancers seemed to prolong the disease-free interval of patients (P = 0.03). Annexin XI immunoreactivity inversely correlated with in vitro cisplatin resistance in ovarian cancers (P = 0.01).Decreased expression of Annexin XI is characteristic for cisplatin-resistant cancer cells and may contribute to tumor recurrence. Annexin XI may be a potential marker for chemoresistance and earlier recurrence of ovarian cancer patients." @default.
• W2115413209 created "2016-06-24" @default.
• W2115413209 creator A5009863325 @default.
• W2115413209 creator A5014887786 @default.
• W2115413209 creator A5045839676 @default.
• W2115413209 creator A5078939311 @default.
• W2115413209 creator A5079992055 @default.
• W2115413209 date "2007-11-15" @default.
• W2115413209 modified "2023-09-25" @default.
• W2115413209 title "Annexin XI Is Associated with Cisplatin Resistance and Related to Tumor Recurrence in Ovarian Cancer Patients" @default.
• W2115413209 cites W1501700213 @default.
• W2115413209 cites W1506940213 @default.
• W2115413209 cites W1576215795 @default.
• W2115413209 cites W1963592300 @default.
• W2115413209 cites W1965392984 @default.
• W2115413209 cites W1966536078 @default.
• W2115413209 cites W1985045616 @default.
• W2115413209 cites W2000776349 @default.
• W2115413209 cites W2004783362 @default.
• W2115413209 cites W2005806432 @default.
• W2115413209 cites W2015261641 @default.
• W2115413209 cites W2020056775 @default.
• W2115413209 cites W2021599981 @default.
• W2115413209 cites W2022594395 @default.
• W2115413209 cites W2028946225 @default.
• W2115413209 cites W2029181794 @default.
• W2115413209 cites W2030014130 @default.
• W2115413209 cites W2033660939 @default.
• W2115413209 cites W2054045089 @default.
• W2115413209 cites W2071568301 @default.
• W2115413209 cites W2080657371 @default.
• W2115413209 cites W2080798710 @default.
• W2115413209 cites W2099521317 @default.
• W2115413209 cites W2102596101 @default.
• W2115413209 cites W2103891110 @default.
• W2115413209 cites W2131947231 @default.
• W2115413209 cites W2135178321 @default.
• W2115413209 cites W2164277862 @default.
• W2115413209 cites W2166933821 @default.
• W2115413209 doi "https://doi.org/10.1158/1078-0432.ccr-07-0569" @default.
• W2115413209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17982121" @default.
• W2115413209 hasPublicationYear "2007" @default.
• W2115413209 type Work @default.
• W2115413209 sameAs 2115413209 @default.
• W2115413209 citedByCount "41" @default.
• W2115413209 countsByYear W21154132092012 @default.
• W2115413209 countsByYear W21154132092013 @default.
• W2115413209 countsByYear W21154132092014 @default.
• W2115413209 countsByYear W21154132092015 @default.
• W2115413209 countsByYear W21154132092016 @default.
• W2115413209 countsByYear W21154132092018 @default.
• W2115413209 countsByYear W21154132092019 @default.
• W2115413209 countsByYear W21154132092021 @default.
• W2115413209 countsByYear W21154132092022 @default.
• W2115413209 countsByYear W21154132092023 @default.
• W2115413209 crossrefType "journal-article" @default.
• W2115413209 hasAuthorship W2115413209A5009863325 @default.
• W2115413209 hasAuthorship W2115413209A5014887786 @default.
• W2115413209 hasAuthorship W2115413209A5045839676 @default.
• W2115413209 hasAuthorship W2115413209A5078939311 @default.
• W2115413209 hasAuthorship W2115413209A5079992055 @default.
• W2115413209 hasBestOaLocation W21154132091 @default.
• W2115413209 hasConcept C121608353 @default.
• W2115413209 hasConcept C126322002 @default.
• W2115413209 hasConcept C142724271 @default.
• W2115413209 hasConcept C143998085 @default.
• W2115413209 hasConcept C193270364 @default.
• W2115413209 hasConcept C204232928 @default.
• W2115413209 hasConcept C2776694085 @default.
• W2115413209 hasConcept C2778239845 @default.
• W2115413209 hasConcept C2780427987 @default.
• W2115413209 hasConcept C2781100745 @default.
• W2115413209 hasConcept C502942594 @default.
• W2115413209 hasConcept C68246026 @default.
• W2115413209 hasConcept C71924100 @default.
• W2115413209 hasConcept C74864618 @default.
• W2115413209 hasConcept C86803240 @default.
• W2115413209 hasConcept C88634738 @default.
• W2115413209 hasConceptScore W2115413209C121608353 @default.
• W2115413209 hasConceptScore W2115413209C126322002 @default.
• W2115413209 hasConceptScore W2115413209C142724271 @default.
• W2115413209 hasConceptScore W2115413209C143998085 @default.
• W2115413209 hasConceptScore W2115413209C193270364 @default.
• W2115413209 hasConceptScore W2115413209C204232928 @default.
• W2115413209 hasConceptScore W2115413209C2776694085 @default.
• W2115413209 hasConceptScore W2115413209C2778239845 @default.
• W2115413209 hasConceptScore W2115413209C2780427987 @default.
• W2115413209 hasConceptScore W2115413209C2781100745 @default.
• W2115413209 hasConceptScore W2115413209C502942594 @default.
• W2115413209 hasConceptScore W2115413209C68246026 @default.
• W2115413209 hasConceptScore W2115413209C71924100 @default.
• W2115413209 hasConceptScore W2115413209C74864618 @default.
• W2115413209 hasConceptScore W2115413209C86803240 @default.
• W2115413209 hasConceptScore W2115413209C88634738 @default.
• W2115413209 hasIssue "22" @default.
• W2115413209 hasLocation W21154132091 @default.
• W2115413209 hasLocation W21154132092 @default.
• W2115413209 hasOpenAccess W2115413209 @default.

• next